GlobeNewswire·Nov 20, 2025, 1:54 PM ET

BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

Faruqi & Faruqi, LLP is investigating potential federal securities class action claims against Baxter International Inc. (NYSE: BAX).
The lawsuit covers the period from February 23, 2022, to July 30, 2025, for investors who purchased or acquired Baxter securities during this timeframe.
Investors seeking the role of lead plaintiff must file a motion by the December 15, 2025 deadline.
The complaint alleges Baxter violated securities laws by making false or misleading statements regarding the safety of its Novum LVP infusion pumps.
Allegations include systemic defects in Novum LVPs causing underinfusion, overinfusion, or non-delivery of fluids, leading to patient injury or death.
Baxter is accused of failing to disclose known device malfunctions, injuries, and deaths despite receiving multiple reports.
The firm claims Baxter's remedial customer alerts were inadequate because design flaws persisted and continued to harm patients.
On July 31, 2025, Baxter announced a voluntary pause on shipments & installations of Novum LVPs, causing stock to drop 22.4% to close at $21.76.
The firm is seeking information from whistleblowers, former employees, shareholders, & others regarding Baxter's conduct.
Investors can contact partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss legal rights.
Additional information is available at www.faruqilaw.com/BAX.